Published in Cancer Res on September 01, 1989
Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters. BMC Complement Altern Med (2011) 1.22
The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties. Glycoconj J (2013) 0.99
Down-regulation of some miRNAs by degrading their precursors contributes to anti-cancer effect of mistletoe lectin-I. Br J Pharmacol (2011) 0.93
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immunol (2006) 0.91
Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model. Br J Cancer (2007) 0.91
Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications. Evid Based Complement Alternat Med (2005) 0.90
Mucosal immunogenicity of plant lectins in mice. Immunology (2000) 0.88
Recombinant mistletoe lectin induces p53-independent apoptosis in tumour cells and cooperates with ionising radiation. Br J Cancer (2003) 0.86
Effect of gamma irradiation on mistletoe (Viscum album) lectin-mediated toxicity and immunomodulatory activity. FEBS Open Bio (2013) 0.79
Small angle neutron scattering as sensitive tool to detect ligand-dependent shape changes in a plant lectin with beta-trefoil folding and their dependence on the nature of the solvent. Glycoconj J (2008) 0.78
The effects of chloroform, ethyl acetate and methanolic extracts of Brassica rapa L. on cell-mediated immune response in mice. Res Pharm Sci (2013) 0.78
Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine. Evid Based Complement Alternat Med (2011) 0.77
Unexpected different binding of mistletoe lectins from plant extracts to immobilized lactose and N-acetylgalactosamine. Anal Chem Insights (2007) 0.76
Influence of mistletoe ( Viscum album) extracts on phagocytosis/burst activity of human phagocytes. Eur J Clin Microbiol Infect Dis (2003) 0.76
Production of Active Nonglycosylated Recombinant B-Chain of Type-2 Ribosome-Inactivating Protein from Viscum articulatum and Its Biological Effects on Peripheral Blood Mononuclear Cells. Evid Based Complement Alternat Med (2011) 0.75
Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch (2000) 1.97
An RNA ligase from wheat germ which participates in transfer RNA splicing in vitro. J Biol Chem (1983) 1.70
[Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks]. Dtsch Med Wochenschr (2002) 1.48
[Immunomodulating mistletoe therapy by lectin standardization: a double-edged sword?]. Versicherungsmedizin (1999) 1.41
Receptor for the cell binding site of discoidin I. Cell (1985) 1.28
The amino-acid sequence of the abalone (Haliotis laevigata) nacre protein perlucin. Detection of a functional C-type lectin domain with galactose/mannose specificity. Eur J Biochem (2000) 1.26
Plant lectins: occurrence, biochemistry, functions and applications. Glycoconj J (2001) 1.22
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol (2001) 1.17
Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem (2001) 1.14
Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci (1999) 1.12
Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res (1990) 1.11
Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. Eur J Cardiothorac Surg (2001) 1.09
Differences in zero-force and force-driven kinetics of ligand dissociation from beta-galactoside-specific proteins (plant and animal lectins, immunoglobulin G) monitored by plasmon resonance and dynamic single molecule force microscopy. Arch Biochem Biophys (2000) 1.06
Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res (1995) 1.03
Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates. Chembiochem (2001) 1.02
Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia (2001) 1.01
Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem (1998) 1.01
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol (2001) 0.99
Are there characteristic alterations in lung tissue associated with Crohn's disease? Pathol Res Pract (1990) 0.99
Dietary lectins can induce in vitro release of IL-4 and IL-13 from human basophils. Eur J Immunol (1999) 0.97
Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of neoglycoprotein in the histochemical detection of lectins. Bioconjug Chem (1991) 0.97
The application of thermodynamic principles to histochemical and morphometric tissue research: principles and practical outline with focus on the glycosciences. Cell Tissue Res (1999) 0.97
Structural basis for chitin recognition by defense proteins: GlcNAc residues are bound in a multivalent fashion by extended binding sites in hevein domains. Chem Biol (2000) 0.97
Receptors for carbohydrate ligands including heparin on the cell surface of Leishmania and other trypanosomatids. Trop Med Int Health (1997) 0.96
Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.95
Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients. J Pathol (2001) 0.95
Isolation and biochemical characterization of heparin-binding proteins from boar seminal plasma: a dual role for spermadhesins in fertilization. Mol Reprod Dev (1993) 0.94
Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart. Int J Biochem (1993) 0.94
Purification and properties of a Ca2+-independent sialic acid-binding lectin from human placenta with preferential affinity to O-acetylsialic acids. J Biol Chem (1989) 0.93
Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope (1999) 0.92
Diffuse pulmonary hemosiderosis after exposure to pesticides. A case report. Respiration (1998) 0.92
Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. Glycobiology (1999) 0.92
Activity patterns of aminoacyl-tRNA synthetases, tRNA methylases, arginyltransferase and tubulin: tyrosine ligase during development and ageing of Caenorhabditis elegans. Eur J Biochem (1983) 0.92
Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol (2001) 0.92
Application of attributed graphs in diagnostic pathology. Anal Quant Cytol Histol (1996) 0.91
Parameters derived from integrated nuclear fluorescence, syntactic structure analysis, and vascularization in human lung carcinomas. Anal Cell Pathol (1997) 0.90
Heparin-binding lectin from human placenta: further characterization of ligand binding and structural properties and its relationship to histones and heparin-binding growth factors. Biochemistry (1991) 0.90
Analysis of expression of erythropoietin-binding sites in human lung carcinoma by the biotinylated ligand. Zentralbl Pathol (1992) 0.89
Towards defining the role of glycans as hardware in information storage and transfer: basic principles, experimental approaches and recent progress. Cells Tissues Organs (2001) 0.88
Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev (2000) 0.88
Sialic acids structure-analysis-metabolism-occurrence-recognition. Biol Chem Hoppe Seyler (1996) 0.88
Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L. J Pharm Pharmacol (2005) 0.88
Activation of human neutrophils by the plant lectin Viscum album agglutinin-I: modulation of de novo protein synthesis and evidence that caspases are involved in induction of apoptosis. J Leukoc Biol (2000) 0.87
Necrotizing bronchitis, angiitis, and amyloidosis associated with chronic Q fever. Respiration (1995) 0.87
Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome. Histol Histopathol (1999) 0.87
Association of prognosis in surgically treated lung cancer patients with cytometric, histometric and ligand histochemical properties: with an emphasis on structural entropy. Anal Quant Cytol Histol (1998) 0.86
Detection of galectin-3 in tear fluid at disease states and immunohistochemical and lectin histochemical analysis in human corneal and conjunctival epithelium. Br J Ophthalmol (2001) 0.86
Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol (1999) 0.86
Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3 binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors. Am J Clin Pathol (1999) 0.85
Ligand binding characteristics of the major mistletoe lectin. J Biol Chem (1992) 0.85
An 8- to 10-fold enhancement in sensitivity for quantitation of proteins by modified application of colloidal gold. Anal Biochem (1988) 0.85
Carbohydrate specificity of a galectin from chicken liver (CG-16). Biochem J (2001) 0.85
The sugar-combining area of the galactose-specific toxic lectin of mistletoe extends beyond the terminal sugar residue: comparison with a homologous toxic lectin, ricin. Carbohydr Res (1994) 0.84
Different architecture of the combining site of the two chicken galectins revealed by chemical mapping studies with synthetic ligand derivatives. J Biol Chem (1996) 0.84
Cellular glycoconjugates and their potential endogenous receptors in the cerebral microvasculature of man: a glycohistochemical study. Eur J Cell Biol (1988) 0.84
In vitro characterization of lectin-induced alterations on the proliferative activity of three human melanoma cell lines. Melanoma Res (1997) 0.84
Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. Glycobiology (1996) 0.84
Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer (2001) 0.84
Correlation of expression of binding sites for synthetic blood group A-, B- and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer (1994) 0.84
Detection of inflammation- and neoplasia-associated alterations in human large intestine using plant/invertebrate lectins, galectin-1 and neoglycoproteins. Acta Anat (Basel) (1998) 0.83
Paraganglioma of the lung--developed after exposure to nuclear radiation by the Tschernobyl atomic reactor accident? Respiration (1994) 0.83
Evolutionary aspects of accuracy of phenylalanyl-tRNA synthetase. A comparative study with enzymes from Escherichia coli, Saccharomyces cerevisiae, Neurospora crassa, and turkey liver using phenylalanine analogues. Biochemistry (1983) 0.83
Effect of chemical structure of hydrogels on the adhesion and phenotypic characteristics of human monocytes such as expression of galectins and other carbohydrate-binding sites. Biomaterials (1997) 0.83
Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador). Eur J Cancer (1991) 0.83
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol (1996) 0.83
Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins. Mol Cell Biochem (1995) 0.83
Endogenous lectins in tumors and the immune system. Cancer Invest (1987) 0.83
Efficient induction of superoxide release from human neutrophils by the galactoside-specific lectin from Viscum album. Biol Chem Hoppe Seyler (1993) 0.83
NMR investigations of protein-carbohydrate interactions: insights into the topology of the bound conformation of a lactose isomer and beta-galactosyl xyloses to mistletoe lectin and galectin-1. Biochim Biophys Acta (2001) 0.82
Endobronchial juvenile hemangioma--a case report of a neonate including immunohistochemical monitoring and nuclear, cellular, and vascular morphometry. Virchows Arch (2001) 0.81
Differential expression of calcyclin and its accessible ligands in various types of cutaneous tumors. J Dermatol Sci (1995) 0.81
The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor. Arch Biochem Biophys (1993) 0.81
A new combined computational and NMR-spectroscopical strategy for the identification of additional conformational constraints of the bound ligand in an aprotic solvent. Chembiochem (2000) 0.81
Biotinylated epidermal growth factor: a useful tool for the histochemical analysis of specific binding sites. Histochem J (1990) 0.81
Neoglycoprotein-liposome and lectin-liposome conjugates as tools for carbohydrate recognition research. Methods Enzymol (1994) 0.81
Evolutionary aspects of accuracy of phenylalanyl-tRNA synthetase. Accuracy of fungal and animal mitochondrial enzymes and their relationship to their cytoplasmic counterparts and a prokaryotic enzyme. Biochemistry (1983) 0.81
Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol (2001) 0.81
Immunomodulatory effects of Viscum album agglutinin-I on natural immunity. Anticancer Drugs (1997) 0.81
Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81
Expression of galectin-1 and -3 and of accessible binding sites during murine hair cycle. Histol Histopathol (2000) 0.81
The levels of retinoid RARbeta receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas. Hear Res (2001) 0.80
Detection of receptors for sulfated polysaccharides in human placenta by biotinylated probes. J Histochem Cytochem (1988) 0.80
Lectin-binding sites in the epithelium of normal human appendix vermiformis and in acute appendicitis. Histol Histopathol (1995) 0.80
Contribution of carbohydrate histochemistry to glycobiology. Histol Histopathol (1994) 0.80
NMR investigations of protein-carbohydrate interactions binding studies and refined three-dimensional solution structure of the complex between the B domain of wheat germ agglutinin and N,N', N"-triacetylchitotriose. Eur J Biochem (2000) 0.80
The 2.15 A crystal structure of CG-16, the developmentally regulated homodimeric chicken galectin. J Mol Biol (1999) 0.80
In vitro influence of lectins and neoglycoconjugates on the growth of three human sarcoma cell lines. J Cancer Res Clin Oncol (1999) 0.80
Preneoplasia-associated expression of calcyclin and of binding sites for synthetic blood group A/H trisaccharide--exposing neoglycoconjugates in human lung. Cancer Biochem Biophys (1997) 0.80